AIM: To investigate the optimal strategy to treat dyspeptic patients in primary care. METHODS:Dyspeptic patients presenting to primary care outpatient clinics were randomly assigned to: (1) empirical endoscopy, (2) H pylori test-and-treat, and (3) empirical prokinetic treatment with cisapride. Early endoscopy was arranged if patients remained symptomatic after 2 wk. Symptom severity, quality-of-life (SF-36) as well as patient preference and satisfaction were assessed. All patients underwent endoscopy by wk 6. Patients were followed up for one year. RESULTS:Two hundred and thirty four patients were recruited (163 female, mean age 49). 46% were H pylori positive. 26% of H pylori tested and 25% of empirical prokinetic patients showed no improvement at wk 2 follow-up and needed early endoscopy. 15% of patients receiving empirical cisapride responded well to treatment but peptic ulcer was the final diagnosis. Symptom resolution and quality-of-life were similar among the groups. Costs for the three strategies were HK dollar 4343, dollar 1771 and dollar 1750 per patient. 66% of the patients preferred to have early endoscopy. CONCLUSION: The three strategies are equally effective. Empirical prokinetic treatment was the least expensive but peptic ulcers may be missed with this treatment. The H pylori test-and-treat was the most cost-effective option.
RCT Entities:
AIM: To investigate the optimal strategy to treat dyspeptic patients in primary care. METHODS: Dyspeptic patients presenting to primary care outpatient clinics were randomly assigned to: (1) empirical endoscopy, (2) H pylori test-and-treat, and (3) empirical prokinetic treatment with cisapride. Early endoscopy was arranged if patients remained symptomatic after 2 wk. Symptom severity, quality-of-life (SF-36) as well as patient preference and satisfaction were assessed. All patients underwent endoscopy by wk 6. Patients were followed up for one year. RESULTS: Two hundred and thirty four patients were recruited (163 female, mean age 49). 46% were H pylori positive. 26% of H pylori tested and 25% of empirical prokinetic patients showed no improvement at wk 2 follow-up and needed early endoscopy. 15% of patients receiving empirical cisapride responded well to treatment but peptic ulcer was the final diagnosis. Symptom resolution and quality-of-life were similar among the groups. Costs for the three strategies were HK dollar 4343, dollar 1771 and dollar 1750 per patient. 66% of the patients preferred to have early endoscopy. CONCLUSION: The three strategies are equally effective. Empirical prokinetic treatment was the least expensive but peptic ulcers may be missed with this treatment. The H pylori test-and-treat was the most cost-effective option.
Authors: A L Blum; N J Talley; C O'Moráin; S V van Zanten; J Labenz; M Stolte; J A Louw; A Stubberöd; A Theodórs; M Sundin; E Bolling-Sternevald; O Junghard Journal: N Engl J Med Date: 1998-12-24 Impact factor: 91.245
Authors: M B Wallace; V L Durkalski; J Vaughan; Y Y Palesch; E D Libby; P S Jowell; N J Nickl; S M Schutz; J W Leung; P B Cotton Journal: Gut Date: 2001-07 Impact factor: 23.059
Authors: B C Wong; C K Chan; K W Wong; W M Wong; M F Yuen; K C Lai; W H Hu; G K Lau; C L Lai; S K Lam Journal: J Gastroenterol Hepatol Date: 2000-11 Impact factor: 4.029
Authors: W M Wong; B C Wong; K W Wong; F M Fung; K C Lai; W H Hu; S T Yuen; S Y Leung; G K Lau; C L Lai; C K Chan; R Go; S K Lam Journal: Aliment Pharmacol Ther Date: 2000-10 Impact factor: 8.171
Authors: N P Breslin; A B Thomson; R J Bailey; P K Blustein; J Meddings; E Lalor; G M VanRosendaal; M J Verhoef; L R Sutherland Journal: Gut Date: 2000-01 Impact factor: 23.059
Authors: Alan N Barkun; Ralph Crott; Carlo A Fallone; Wendy A Kennedy; Jean Lachaine; Carey Levinton; David Armstrong; Naoki Chiba; Alan Thomson; Sander Veldhuyzen van Zanten; Paul Sinclair; Sergio Escobedo; Bijan Chakraborty; Sandra Smyth; Robert White; Helen Kalra; Krista Nevin Journal: Can J Gastroenterol Date: 2010-08 Impact factor: 3.522